VOCLENNA Trademark

Trademark Overview


On Wednesday, October 18, 2017, a trademark application was filed for VOCLENNA with the United States Patent and Trademark Office. The USPTO has given the VOCLENNA trademark a serial number of 87650583. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 24, 2025. This trademark is owned by Pfizer Inc.. The VOCLENNA trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; ] pharmaceutical preparations for the treatment of blood disorders [, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use ]
voclenna

General Information


Serial Number87650583
Word MarkVOCLENNA
Filing DateWednesday, October 18, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 24, 2025
Registration Number5723165
Registration DateTuesday, April 9, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2018

Trademark Statements


Goods and Services[ Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; ] pharmaceutical preparations for the treatment of blood disorders [, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use ]
Amendment to a Registration/Renewal CertificateIn the statement, line 4, through line 11, is deleted, and pharmaceutical preparations for the treatment of blood disorders is inserted.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 24, 2025
Primary Code005
First Use Anywhere DateThursday, January 31, 2019
First Use In Commerce DateThursday, January 31, 2019

Trademark Owner History


Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Saturday, October 21, 2017NEW APPLICATION ENTERED
Friday, October 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 3, 2018ASSIGNED TO EXAMINER
Monday, January 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 17, 2018SOU TEAS EXTENSION RECEIVED
Monday, September 17, 2018SOU EXTENSION 1 FILED
Monday, September 17, 2018SOU EXTENSION 1 GRANTED
Wednesday, September 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 8, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, February 27, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 8, 2019USE AMENDMENT FILED
Monday, March 4, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, March 4, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 5, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 9, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, May 1, 2019TEAS SECTION 7 REQUEST RECEIVED
Wednesday, May 15, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 16, 2019AMENDMENT UNDER SECTION 7 - PROCESSED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 9, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 24, 2025CANCELLED SEC. 8 (6-YR)